Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: A prospective randomized double-blind trial

Archives of Internal Medicine

Volumn 166, Issue 14, 2006, Pages 1476-1482

  Nielsen, Viveque Egsgaard ^a   Bonnema, Steen Joop ^a   Boel Jørgensen, Henrik ^a   Grupe, Peter ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PREDNISOLONE; RECOMBINANT THYROTROPIN; THIAMAZOLE;

ADULT; AGED; ARTICLE; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG HALF LIFE; DRUG POTENTIATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; THYROID FUNCTION; THYROID WEIGHT;

ADULT; AGED; ANTITHYROID AGENTS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; THYROID HORMONES; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 33746419680     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.14.1476     Document Type: Article

References (25)

1. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24:102-132.
2. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedüs L. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab. 2002;87:112-117.
3. Bhagat MC, Dhaliwal SS, Bonnema SJ, Hegedüs L, Walsh JP. Differences between endocrine surgeons and endocrinologists in the management of nontoxic multinodular goitre. Br J Surg. 2003;90:1103-1112.
4. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic nontoxic goitre. Lancet. 1990;336:193-197.
5. Wesche MF, Tiel V, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab. 2001;86:998-1005.
6. al Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M, Graversen HP. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg. 1997;163:13-20.
7. Pena S, Arum S, Cross M, et al. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab. 2005;91:506-510.
8. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, et al. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab. 2000;85:3592-3596.
9. Nieuwlaat WA, Huysmans DA, van den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab. 2003;88:3121-3129.
10. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab. 2001;86:1660-1664.
11. Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Veje A, Hegedüs L. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab. 2005;90:79-83.
12. Albino CC, Mesa CO Jr, Olandoski M, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab. 2005;90:2775-2780.
13. Silva MN, Rubio IGS, Romao R, et al. Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf). 2004;60:300-308.
14. Cohen O, Ilany J, Hoffman C, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol. 2006;154:243-252.
15. Cubas ER, Gilberto P, Boeving A, et al. Treatment of multinodular goiter with low doses of recombinant human TSH before a low and fixed dose of 131I: a randomized, double-blinded, placebo-controlled study. Paper presented at: the 13th International Thyroid Congress; October 30-November 4, 2005; Buenos Aires, Argentina.
16. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf). 2000;53:479-485.
17. Hegedüs L, Perrild H, Poulsen LR, et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab. 1983;56:260-263.
18. Nielsen VE, Bonnema SJ, Hegedüs L. Effects of 0.9 mg recombinant human TSH on thyroid size and function, in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab. 2004;89:2242-2247.
19. Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab. 1999;84:3636-3641.
20. Le Moli R, Wesche MF, Tiel-van Buul MM, Wiersinga WM. Determinants of long-term outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf). 1999;50:783-789.
21. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab. 2001;86:5330-5336.
22. Nielsen VE, Bonnema SJ, Hegedüs L. Transient goiter enlargement after administration of 0.3 mg recombinant human thyrotropin (rhTSH) in patients with benign nontoxic nodular goiter: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab. 2006;91:1317-1322.
23. Nygaard B, Faber J, Hegedüs L. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Clin Endocrinol (Oxf). 1994;41:715-718.
24. de Klerk JM, van Isselt JW, van Dijk A, et al. Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med. 1997;38:372-376.
25. Nygaard B, Hegedüs L, Gervil M, Hjalmgrim H, Soe-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ. 1993;307:828-832.